The antibiotic pipeline has shrunk 35 percent in five years, falling behind growing antimicrobial resistance worldwide, according to a new report. View on euronews ...

The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the pharmaceutical sector that provides outsourced drug development and manufacturing ...

Recent developments in the biopharma AI world include an alliance between Thermo and Datavant, plus news from Insilico, Evinova, BPGbio, Evogene, and AMPLY. Thermo Fisher Scientific's PPD clinical ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

Hidden Creek Wellness Retreat supports adolescents struggling with substance use through therapy, recovery programs, ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.

A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the agency’s bureaucracy affects innovation, with one witness testifying that ...